SIMCERE PHARMA
Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a research and development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.
SIMCERE PHARMA
Industry:
Biotechnology Manufacturing
Founded:
1995-01-01
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.simcere.com
Total Employee:
1001+
Status:
Active
Contact:
+025-85566666
Total Funding:
600 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content ASP.NET IIS DigiCert SSL ASP.NET 4.0 IIS 8 RapidSSL
Similar Organizations
Advanced Enzymes
Advanced Enzyme is a research driven company manufacturing enzymes and probiotics and dedicated to marketing eco-safe solutions.
Aesica Pharmaceuticals
Aesica Pharmaceuticals Ltd. develops, manufactures, and supplies active pharmaceutical ingredients, formulations, and custom synthesis
B&T Biotech
B&T Biotech is a manufacturer of aquatic microbial preparation products.
Centre for Cellular and Molecular Platforms
Centre for Cellular and Molecular Platforms is an enabler or catalyst of cutting-edge research and innovation in the life sciences.
Enologica Vason
Enologica Vason is a family-run business that offers specialized services for companies in the beverage industry.
Excell Biology
Excell Biology is a supplier of raw materials to the biopharmaceutical and precision medicine industries.
Graphenea
Graphenea is leader in graphene production, producing CVD graphene wafers and Graphene Oxide materials.
Happiness Development Group
Happiness Development Group is an innovative China-based nutraceutical and dietary supplements producer.
Hemmo Pharmaceuticals
Hemmo Pharma is a manufacturer of Peptide-based pharmaceuticals, supplying quality products for the last 37 years.
Innovita Biological Technology
Innovita Biological Technology provides R&D, manufacturing, marketing and after-sales service of In-vitro diagnostic tests.
Kuaifawu.com
Kuaifawu.com provides company registration, taxation, patent and trademark registration to Chinese start-ups and SMEs.
Microdermis
Microdermis manufactures and markets skin care products for skin repair and protection, antimicrobial, and dental skin care.
Neusoft Medical Systems
Neusoft Medical Systems is a leading manufacturer of medical equipment and service in china.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Redbud Labs
Redbud Labs develops and manufactures MEMS and microfluidics technologies for the life science industry.
Seegene
Seegene, Inc. is an in-vitro diagnostics (IVD) company that has been turning concepts into products through its pioneering R&D activities.
Setsuro Tech
Setsuro Tech is a Business Information Systems service platform.
Sun Pharmaceutical Industries
Sun Pharmaceutical Industries is a specialized generic pharmaceutical firm that provides high-quality, low-cost medicines.
Symbiosis Pharmaceutical Services
A leading GMP contract manufacturer of novel injectable pharmaceuticals for use in clinical trials.
Tokiwa Bio
Tokiwa Bio is a manufacturing and development company.
United Water
United Water is a Chinese water and wastewater treatment provider.
Wuxi Vision Pro
Wuxi Vision Pro is an emerging in ophthalmic materials and devices.
Xinheng
Xinheng manufactures and sells automatic Chinese medicine dispensing & decoction equipment.
Current Advisors List
Advisor
2019-01-01
Current Employees Featured
Jinsheng Ren Founder & Chairman @ Simcere Pharma
Founder & Chairman
Jindong Zhou Executive Vice President @ Simcere Pharma
Executive Vice President
Founder
Stock Details
Investors List
HosenCare Brothers
HosenCare Brothers investment in Series B - Simcere Pharma
Jolmo Capital
Jolmo Capital investment in Series B - Simcere Pharma
CITIC Medical Fund
CITIC Medical Fund investment in Series B - Simcere Pharma
Nanjing Innovation Capital Group
Nanjing Innovation Capital Group investment in Series B - Simcere Pharma
CITIC Securities
CITIC Securities investment in Series B - Simcere Pharma
Hongcheng Capital
Hongcheng Capital investment in Series B - Simcere Pharma
Shanghai Creation Investment
Shanghai Creation Investment investment in Series B - Simcere Pharma
Yingke Capital
Yingke Capital investment in Series B - Simcere Pharma
Tianhui Chuangtou
Tianhui Chuangtou investment in Series B - Simcere Pharma
GP Capital
GP Capital investment in Series B - Simcere Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-02-26 | Amwise Diagnostic | Simcere Pharma investment in Series B - Amwise Diagnostic | 10 M USD |
| 2016-10-17 | Veritas Genetics | Simcere Pharma investment in Series B - Veritas Genetics | 30 M USD |
Official Site Inspections
http://www.simcere.com Semrush global rank: 1.97 M Semrush visits lastest month: 10.87 K
- Host name: 58.213.132.85
- IP address: 58.213.132.85
- Location: Nanjing China
- Latitude: 32.0617
- Longitude: 118.7778
- Timezone: Asia/Shanghai
More informations about "Simcere Pharma"
Simcere
Simcere Zaiming will present 7 innovative researches at the 2025 AACR. 2025-04-15 Simcere Zaiming’s FGFR2b targeting ADC SIM0686 obtained IND approval from China NMPA 2025-04-10 NDA of Deunoxavir Marboxil ,the Next …See details»
Simcere Pharmaceutical - Wikipedia
Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业, SEHK: 2096) is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market.Its focus …See details»
Simcere Pharmaceutical Group - LinkedIn
Simcere Pharmaceutical Group Limited (2096.HK) is a pharmaceutical company driven by innovative R&D and committed to synergistic innovation. It has established the State Key Laboratory of ...See details»
Simcere Pharma - Crunchbase Company Profile & Funding
Simcere Pharma develops and supplies pharmaceuticals targeting cancer treatment, focusing on innovative therapies to address oncological diseases. Central Nervous System The company …See details»
Simcere Pharmaceutical Group - Overview, News & Similar
Jul 24, 2023 Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA NANJING, China, June 26, 2024 /PRNewswire/ -- On June 25, 2024, Simcere Zaiming, an …See details»
Simcere Pharmaceutical Group Limited
On April 10, 2025, Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group (2096.HK), announced that its independen... 2025-04-10 NDA of Deunoxavir Marboxil ,the Next Generation Innovative …See details»
Simcere | Top Pharma Tech Company in APAC-2021
NANJING - Simcere Pharmaceutical Group Limited ("Simcere") entered into an exclusive license and collaboration agreement (the "Agreement") with Connect Biopharma HongKong Limited ("Connect") in relation to Rademikibart, an …See details»
Simcere
Simcere has been continuously expanding its R&D investments. In 2022, its R&D investment was more than CNY 1.7 billion, accounting for 27.3% of the sales revenue. With five R&D centers in Shanghai, Nanjing, Beijing, Boston and …See details»
Simcere Pharmaceutical Group Ltd - Company Profile
Simcere’s products are used for the treatment of oncology, infectious diseases, neurology, anti-inflammation and also cardiovascular diseases. The company conducts research and …See details»
Simcere Pharmaceutical Group - BIO International Convention 2025
Simcere Pharmaceutical Group Biotech or pharma, therapeutic R&D Simcere is a pioneering pharmaceutical company driven by innovative R&D. Expanding into disease areas with …See details»
Simcere
Simcere’s Transactions leaders are experienced in cross-border and international biopharmaceutical and medical device deal-making. Each operates with the high standards of …See details»
Simcere
Telephone: 025-85566666 . Address: 699-18 Xuanwu Avenue Nanjing China. Zipcode：210042. Fax：025-85471729See details»
Simcere Pharmaceutical Group Limited
Jun 13, 2023 Simcere Pharmaceutical Group Limited (2096.HK) is an innovation and R&D-driven pharmaceutical company. The Company focuses on three therapeutic areas, oncology, …See details»
Jiangsu Simcere Pharmaceutical Co., Ltd. - Drug pipelines
Key Players Regor Therapeuics Seagen Inc. CytomX Therapeutics Taizhou EOC Pharma Chia Tai Tianqing Pharmaceutical Group AstraZeneca Daiichi Sankyo, Inc. Tyme, Inc. Seagen Inc. …See details»
Simcere Pharmaceutical Group Limited
Jan 13, 2025 Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma Release time：2025-01-13 Shanghai China, and …See details»
Simcere
Jun 13, 2023 Simcere Pharmaceutical Group Limited (2096.HK) is an innovation and R&D-driven pharmaceutical company. The Company focuses on three therapeutic areas, oncology, …See details»
Simcere Pharmaceutical Group Limited
Apr 8, 2022 Simcere Pharmaceutical Group is an innovation and R&D-driven pharmaceutical company. It has established a National Key Laboratory of Translational Medicine and …See details»
Simcere
Dec 28, 2020 Simcere Pharmaceutical Group Announces 2021 Interim Results | Solid Revenue Growth Driven by Sanbexin®, and Rapid Progress in Innovative R&D. Release time：2021-08 …See details»
Simcere Pharmaceutical Group Limited
May 12, 2025 Simcere Zaiming Announces Phase 3 Clinical Trial Results for Cetuximab β Injection (Enlituo) Release time：2025-05-12 On May 10, 2025, Simcere Zaiming, an …See details»
Simcere
Jun 7, 2022 On May 31, 2022, Simcere Pharmaceuticals (2096.HK) released the 2021 Environmental, Social and Governance (ESG) Report. This report comprehensively shows the …See details»